-
The Unique Value of Detecting Preeclampsia: Comparing Health Economic Analyses of Novel Diagnostics With the ISPOR Value Flower
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
Bridging the Regulatory-Payer Evidence Gap: A Case Study With Six Minute Walk Distance and Mortality
Sep 9, 2025, 16:22 PM -
What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024
Sep 9, 2025, 16:22 PM -
Validating a Medication Adherence Index in Large Urban Population
Sep 9, 2025, 16:22 PM -
What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?
Sep 9, 2025, 16:22 PM -
Differences in the Reimbursement Pathway for Ultraorphan Therapies in England and Ireland
Sep 9, 2025, 16:22 PM -
Modeling the Long-Term Bone Health Impact of TDF/FTC PrEP in Adolescent MSM
Sep 9, 2025, 16:22 PM -
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM -
The Economic Burden of Diabetes-Related Blindness and Vision Impairment in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Budgetary Impact of Ultra-Rare Diseases in Brazil: A Review of Decisions From the Past Five Years
Sep 9, 2025, 16:22 PM -
The Use of Oligometastatic Disease in Routine Radiology Practice: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage
Sep 9, 2025, 16:22 PM -
Impact of Inclusion of Drug Adherence on Cost-Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Disease (ASCVD) Patients
Sep 9, 2025, 16:22 PM -
An Interactive Tool to Select Indirect Treatment Comparison Methods for Rapid Feasibility Assessment
Sep 9, 2025, 16:22 PM -
Disability-Associated Economic Burden Among Patients With Wilson’s Disease in South Korea: A Nationwide Cost-of-Illness Study
Sep 9, 2025, 16:22 PM -
A Description of the Incidence and Burden of Hyperkalemia in Irish Hospitals 2022-2024
Sep 9, 2025, 16:22 PM -
Economic and Clinical Burden of Diagnosed Congenital Cytomegalovirus Disease in France During the First 2 Years of Life
Sep 9, 2025, 16:22 PM -
Modeling the Anticipated Organizational Impact on Health Service Provision of the Introduction of Tirbanibulin for the Topical Treatment of Actinic Keratosis in France: EPIKA Study
Sep 9, 2025, 16:22 PM -
Evaluating the Economic Benefit of Improved High-Dose Influenza Vaccine Coverage in the Elderly Population of Tokyo, Japan
Sep 9, 2025, 16:22 PM
